In non-cancer models of muscle atrophy, such as diabetes-induced sarcopenia (66) and angiotensin II-induced wasting (64, 67), PPARγ expression is suppressed, whereas its pharmacological activation alleviates muscle loss and promotes regeneration following injury (68). The gene discussed is PPARG; the disease is cancer.